Breast Implant Market Growth, Price, Demand and Forecasts To 2025 Breast Implant Market - Global Industry Analysis,

Breast Implant Market - Global Industry Analysis, Size, Share,
Growth, Trends, and Forecast 2017 – 2025
Breast implants are medical devices that are used to augment the size of breasts, either for
cosmetic applications or reconstruction purpose, following mastectomy or to correct a congenital
abnormality. Breast augmentation, commonly known as breast enlargement, is a popular surgical
procedure that improves the size and shape of the breast. The procedure involves the use of breast
implants and fat, called as fat transfer breast augmentation, in order to enhance and improve the size
of the breasts. In clinical terms, breast augmentation is referred as augmentation mammoplasty.
According to a statistics by American Society of Plastic Surgeons (ASPS), the average cost of a breast
augmentation surgery was US$ 3,708 in 2014. Socioeconomic status is a primary factor creating a
high demand for breast implants globally. The primary customer base for breast augmentation are
women belonging to middle- and high-income families. The World Bank estimates that the global
annual disposable income per capita for women is expected to increase at a CAGR of approximately
6% in the next few years, driving the expansion of the aesthetic market globally. Additionally,
significant rise of the world’s middle-class population over the last few years, resulting in increase in
purchasing power and discretionary spending, is indicative of the stability and growth of the global
breast implant market. It has been estimated that much of this growth in purchasing power is likely to
come from emerging markets, which is attributed to rising disposable income.
Request for brochure of this report -
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22895
Rise in global disposable income and growth in reimbursement rates for reconstructive procedures
are expected to propel the market growth for breast implant during the forecast period. In addition,
availability of premium-priced products, expansion of product portfolio, and increase in prevalence of
breast cancer are factors driving the global market growth for breast implant. As per data released by
the World Health Organization (WHO), in 2012, 1.7 million women were diagnosed with breast cancer,
leading to approximately 522,000 deaths during the same year. Hence, increase in breast cancer
prevalence is a major factor contributing to revenue growth of the breast implant market across the
globe. However, risk of developing serious complications and lack of skilled nursing facilities in
developing regions may hamper the market share. Large amount of documented evidences supporting
the possibility of developing breast cancer after getting breast implants is one of the prime reasons
hampering the growth of the market. In 2011, FDA indicated possible association between breast
implants (saline and silicone) and anaplastic large-cell lymphoma (ALCL). Anaplastic large-cell
lymphoma is a rare type of non-Hodgkin’s lymphoma (NHL), characterized by abnormal growth of T-
lymphocytes. According to the National Cancer Institute, the disease affects 1 in 500,000 women
globally. However, in the U.S., ALCL affects 3 in 100 million women who have undergone breast
implants surgery.
The global breast implant market is segmented on the basis of implant type, application, end-user,
and region. Based on implant type, the market is categorized into saline breast implants and silicone
breast implants. The silicone breast implants segment is expected to account for a significant share